about
Reactive oxygen species, nutrition, hypoxia and diseases: Problems solved?HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionPHD2: from hypoxia regulation to disease progressionPHD1 links cell-cycle progression to oxygen sensing through hydroxylation of the centrosomal protein Cep192Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidenceCorrelation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients.HIF-1α activation results in actin cytoskeleton reorganization and modulation of Rac-1 signaling in endothelial cellsCurrent views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaOverexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survivalProlyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.Current approaches and recent developments in the management of head and neck paragangliomas.Expression and DNA methylation levels of prolyl hydroxylases PHD1, PHD2, PHD3 and asparaginyl hydroxylase FIH in colorectal cancer.Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels.Hypoxia regulates the expression of the neuromedin B receptor through a mechanism dependent on hypoxia-inducible factor-1αGlioma-derived T cell immunoglobulin- and mucin domain-containing molecule-4 (TIM4) contributes to tumor toleranceNegative regulation of HIF-1α by an FBW7-mediated degradation pathway during hypoxia.Hypoxia-inducible factors and the prevention of acute organ injury.Redox regulation of the epigenetic landscape in cancer: a role for metabolic reprogramming in remodeling the epigenomeEpigenetics, TET proteins, and hypoxia in epithelial-mesenchymal transition and tumorigenesisThe biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia.Prolyl 4-hydroxylases, master regulators of the hypoxia response.Genetic modification of hypoxia signaling in animal models and its effect on cancer.Regulation of mammalian nucleotide metabolism and biosynthesisNuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing.Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy.Prolyl hydroxylase mediated inhibition of fatty acid synthase to combat tumor growth in mammary gland carcinoma.Therapeutic inhibition of prolyl hydroxylase domain-containing enzymes in surgery: putative applications and challenges.Autocrine stimulation of clear-cell renal carcinoma cell migration in hypoxia via HIF-independent suppression of thrombospondin-1.Iron facilitator LS081 reduces hypoxia-inducible factor-1α protein and functions as anticancer agent in hepatocellular carcinoma.Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27.A Genetically Encoded FRET Sensor for Hypoxia and Prolyl Hydroxylases.Uptake of [(18)F]EF5 as a Tracer for Hypoxic and Aggressive Phenotype in Experimental Head and Neck Squamous Cell Carcinoma.Regulators of the hypoxic response: a growing family.
P2860
Q26784413-ACC828A2-9EEE-4E63-9BA7-D7690D723D02Q27025886-4AF496A0-379F-4F18-BDE7-590A7AC40DC6Q28069316-62D019C4-4EFC-4DA3-8670-9FFAF6BFD742Q28296254-33202F36-B194-4FAA-830E-4790B777E426Q28393187-A3D809E1-B94C-4F2A-AC69-83AF059B82CAQ30318094-45A2D495-7B60-482B-96BA-CB07E199C421Q30565644-053F7686-8F55-4A05-8222-D8E2AC4EFF62Q33590969-13418C4D-BA20-46BE-80A8-B2C2679DED80Q34009639-C0B7AE72-63EE-4EDC-882B-6BD1E3C85778Q34075508-4623FC6A-7E05-40C7-9FB4-CB289908B85FQ34204524-AB1EFA42-2398-4F20-83EE-4DD35D0C2054Q35032951-A21F8806-3672-40A3-9146-D666E783B270Q35043607-0EB7A947-4764-4C83-89AB-B93F5EFFB00AQ35070598-18A33BB6-14DC-4B5F-A892-563CCD43DEA9Q35378998-C3882EF5-4625-49E9-A60B-1EB442CFAB2FQ35449110-6468DB13-08B9-4701-B8A7-E0C08403CB4EQ35559650-4C9729F1-13D0-47CE-B1A0-7D04BF590A2AQ36428635-A6B1A7FD-8BD7-4C8C-8F27-00617869F3CAQ36573115-ABAAC533-A31F-4AC8-9F17-66680B9D7C2AQ37210542-2F08718A-94C7-41F6-B0BD-8B902AC81588Q37654508-31200E65-5FD0-47A1-B897-815656DA8D27Q38089239-C4155981-1122-4211-8ACE-F4336BE85D1BQ38263349-4067221F-7FBE-488F-8E14-245EDFD6CBCAQ38335072-56D6E368-ECE0-4A22-8CCB-B85194EB4601Q38391328-A5B9EA4A-DA82-43F6-BEE0-482EE563F703Q38577907-9163A85B-A109-4A71-9E88-69AB42E73106Q38764237-FB134EE7-56E7-4069-B2F0-CC8DFEFEC0D1Q38989150-B38A0AA6-B7F8-424A-A957-F52A9B89DBA7Q39246000-69A9BAFA-DC83-4236-9766-877D7C523F15Q39425760-E9F2F0D0-A975-45BF-8F7B-88046FDDACD5Q40681056-CEFDA17D-D4B0-40F2-A37E-05CD6FF071D9Q41112135-8BF9A403-ACDF-4731-BFC6-64E5E29548B2Q41871576-336F149C-8141-42F7-A5E5-E7BB4C75C7C8Q51595101-E8969D32-701F-4A19-AC86-ADA81B989104
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of HIF prolyl hydroxylases in tumour growth.
@en
The role of HIF prolyl hydroxylases in tumour growth.
@nl
type
label
The role of HIF prolyl hydroxylases in tumour growth.
@en
The role of HIF prolyl hydroxylases in tumour growth.
@nl
prefLabel
The role of HIF prolyl hydroxylases in tumour growth.
@en
The role of HIF prolyl hydroxylases in tumour growth.
@nl
P2860
P921
P1476
The role of HIF prolyl hydroxylases in tumour growth
@en
P2093
Terhi Jokilehto
P2860
P304
P356
10.1111/J.1582-4934.2010.01030.X
P577
2010-02-22T00:00:00Z